Skip to main content

ENDRA Life Sciences Inc.

NDRA
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001681682

No open-market purchases or sales by ENDRA Life Sciences Inc. insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $819.0K in total; no superinvestor holds it.

13F holders, Q2 2026

Institutional positions in ENDRA Life Sciences Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
10
+2 vs. Q1 2026
Shares held
153.7K
+64.0K (+71.4%) vs. Q1 2026
Total value
$819.0K
+$402.2K (+96.5%) vs. Q1 2026
New holders
3
2 more added
Sold out
1
2 more reduced

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting NDRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 10 institutions
Q1 2021: 22 institutionsQ2 2021: 23 institutionsQ3 2021: 20 institutionsQ4 2021: 20 institutionsQ1 2022: 20 institutionsQ2 2022: 20 institutionsQ3 2022: 16 institutionsQ4 2022: 14 institutionsQ1 2023: 14 institutionsQ2 2023: 12 institutionsQ3 2023: 10 institutionsQ4 2023: 11 institutionsQ1 2024: 13 institutionsQ2 2024: 17 institutionsQ3 2024: 11 institutionsQ4 2024: 4 institutionsQ1 2025: 2 institutionsQ2 2025: 3 institutionsQ3 2025: 5 institutionsQ4 2025: 7 institutionsQ1 2026: 8 institutionsQ2 2026: 10 institutions
Value heldQ2 2026: $819.0K
Q1 2021: $8.35MQ2 2021: $7.75MQ3 2021: $6.06MQ4 2021: $3.06MQ1 2022: $1.54MQ2 2022: $1.02MQ3 2022: $1.08MQ4 2022: $569.5KQ1 2023: $384.7KQ2 2023: $267.5KQ3 2023: $156.3KQ4 2023: $284.8KQ1 2024: $153.4KQ2 2024: $80.6KQ3 2024: $32.9KQ4 2024: $720Q1 2025: $4.65KQ2 2025: $16.6KQ3 2025: $70.4KQ4 2025: $325.4KQ1 2026: $416.8KQ2 2026: $819.0K
Institutions holding NDRA and their total value by quarter
QuarterHoldersValue
Q2 202610$819.0K
Q1 20268$416.8K
Q4 20257$325.4K
Q3 20255$70.4K
Q2 20253$16.6K
Q1 20252$4.65K
Q4 20244$720
Q3 202411$32.9K
Q2 202417$80.6K
Q1 202413$153.4K
Q4 202311$284.8K
Q3 202310$156.3K
Q2 202312$267.5K
Q1 202314$384.7K
Q4 202214$569.5K
Q3 202216$1.08M
Q2 202220$1.02M
Q1 202220$1.54M
Q4 202120$3.06M
Q3 202120$6.06M
Q2 202123$7.75M
Q1 202122$8.35M

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding ENDRA Life Sciences Inc.; share changes are against Q1 2026.

Institutions holding NDRA in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Altium Capital Management LP59,272$315.9K0.67%+7,372+14.2%Added
Citadel Advisors LLC29,924$159.5K0.00%+29,924New
Citizens Financial Group Inc28,400$151.4K0.00%+28,400New
Geode Capital Management, LLC14,910$79.5K0.00%−6,168−29.3%Reduced
Vanguard Fiduciary Trust Co10,121$53.9K0.00%00.0%Unchanged
Vanguard Capital Management LLC7,339$39.1K0.00%+4,523+160.6%Added
Morgan Stanley3,546$18.9K0.00%00.0%Unchanged
UBS Group AG68$3620.00%−84−55.3%Reduced
Tower Research Capital LLC (TRC)58$3090.00%+58New
Northwestern Mutual Wealth Management Co19$1010.00%00.0%Unchanged
Caitong International Asset Management Co., Ltd0$00.00%−4−100.0%Sold out